Achieving Equity in Genomic Testing for Breast Cancer Through Partner-Led Strategies and Policies

Breast Cancer Clinical Trial

Official title:

Achieving Equity in Genomic Testing for Breast Cancer Through Partner-Led Strategies and Policies

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05916378
• Other study ID #: 68742
• Status: Recruiting
• Start date: May 22, 2023
• Est. completion date: October 31, 2024

Study information

• Verified date: March 2024
• Source: Stanford University
• Contact: Manali A Patel
• Phone: 6504859462
• Email: manalip[@]stanford.edu
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to identify the barriers, and the extent of said barriers, to genomic testing for breast cancer patients among low-income and minority populations, particularly throughout Northern California. The investigators have created a survey that is available online for any patient with cancer to fill out voluntarily regarding their experiences to date. The survey is available at: https://stanforduniversity.qualtrics.com/jfe/form/SV_7VElf8oesWcB3bE

Description:

The study has two main data-collecting phases. In phase 1, the investigators will engage multilevel stakeholders to respond to a survey assessing experience with and perceptions of genomic testing and its accessibility for patients with breast cancer in California. In phase 2, selected and interested survey participants who voluntarily provide their contact information on the survey will be asked to participate in an in-depth 1:1 semi-structured interview to explore disparities in genomic testing for breast cancer more closely. The investigators will then utilize their findings from both phases to present aggregate findings to an Expert Panel and Community Advisory Board and work together to develop policy recommendations. The policy recommendations will then be presented to policy makers, with the aim of identifying sustainable solutions that address breast cancer treatment and outcome disparities throughout Northern California.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 150
• Est. completion date: October 31, 2024
• Est. primary completion date: October 31, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• The patients must be 18 years or older.
• Patients who opt in to complete the survey.
• Patients must have the capacity to verbally consent for the interview.

Exclusion Criteria:

• Patients who under the age of 18 years old.

Related Conditions & MeSH terms

• Breast Cancer
• Breast Neoplasms

Locations

Country	Name	City	State
United States	Stanford University School of Medicine	Stanford	California

Sponsors (2)

Lead Sponsor	Collaborator
Stanford University	The Latino Cancer Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of participants who fill out the survey and participate in the semi-structured interviews. [ Time Frame: 12 Months ]	We will track the number of participants who fill out the survey for the 12 month duration of the study and the number of participants who participate in the semi-structured telephone interviews.	12 Months